Susceptibility of 324 nonfermentative gram-negative rods to 6 cephalosporins and azthreonam - PubMed (original) (raw)
- PMID: 6311492
- DOI: 10.1159/000238217
Susceptibility of 324 nonfermentative gram-negative rods to 6 cephalosporins and azthreonam
P C Appelbaum et al. Chemotherapy. 1983.
Abstract
Susceptibility of 324 isolates of nonfermentative gram-negative bacteria to cephalothin, cefamandole, cefoxitin, ceftazidime, cefsulodin, and azthreonam was determined by agar dilution and disc diffusion techniques. With the exception of Moraxella species, first- and second-generation cephalosporins were minimally active against nonfermenters tested. Cefsulodin and azthreonam were mainly active against Pseudomonas aeruginosa. In contrast, ceftazidime and ceftriaxone exhibited wider activity spectra. Cefsulodin and ceftazidime were the most active against P. aeruginosa, followed by azthreonam and ceftriaxone. Ceftazidime was the only drug with significant activity against Pseudomonas maltophilia and Pseudomonas fluorescens/Pseudomonas putida, and was also the most active against Pseudomonas cepacia. Acinetobacter calcoaceticus and Alcaligenes strains were most sensitive to ceftazidime, followed by ceftriaxone and azthreonam. Ceftriaxone was the most active against moraxellas, followed by cefamandole/cefoxitin, ceftazidime, cephalothin, cefsulodin, and azthreonam. Ceftazidime was the most active against uncommonly isolated nonfermenters. Results observed in this study reflect a potential use for ceftazidime in therapy of infections caused by most gram-negative nonfermenters; therapy with cefsulodin and azthreonam in nonfermenter infections should be restricted to those caused by P. aeruginosa, and that with ceftriaxone reserved for non-P. aeruginosa infections.
Similar articles
- In vitro activity of ceftazidime and ceftriaxone.
Keenholtz SL, Jacobus NV, Tally FP, Gorbach SL. Keenholtz SL, et al. Clin Ther. 1983;5(6):603-16. Clin Ther. 1983. PMID: 6313195 - The activity of ceftazidime compared with those of aztreonam, newer cephalosporins and Sch 29482 against nonfermentative gram-negative bacilli.
Schell RF, Francisco M, Bihl JA, LeFrock JL. Schell RF, et al. Chemotherapy. 1985;31(3):181-90. doi: 10.1159/000238334. Chemotherapy. 1985. PMID: 3888543 - Cefsulodin and ceftazidime, two antipseudomonal cephalosporins.
Smith BR. Smith BR. Clin Pharm. 1984 Jul-Aug;3(4):373-85. Clin Pharm. 1984. PMID: 6380902 Review. - Drug utilisation review (DUR) of the third generation cephalosporins. Focus on ceftriaxone, ceftazidime and cefotaxime.
Adu A, Armour CL. Adu A, et al. Drugs. 1995 Sep;50(3):423-39. doi: 10.2165/00003495-199550030-00002. Drugs. 1995. PMID: 8521766 Review.
Cited by
- Rapid differentiation of fermentative from nonfermentative gram-negative bacilli in positive blood cultures by an impedance method.
Chang TC, Huang AH. Chang TC, et al. J Clin Microbiol. 2000 Oct;38(10):3589-94. doi: 10.1128/JCM.38.10.3589-3594.2000. J Clin Microbiol. 2000. PMID: 11015369 Free PMC article. - Activities of levofloxacin, ofloxacin, and ciprofloxacin, alone and in combination with amikacin, against acinetobacters as determined by checkerboard and time-kill studies.
Bajaksouzian S, Visalli MA, Jacobs MR, Appelbaum PC. Bajaksouzian S, et al. Antimicrob Agents Chemother. 1997 May;41(5):1073-6. doi: 10.1128/AAC.41.5.1073. Antimicrob Agents Chemother. 1997. PMID: 9145872 Free PMC article. - Activities of beta-lactams against Acinetobacter genospecies as determined by agar dilution and E-test MIC methods.
Visalli MA, Jacobs MR, Moore TD, Renzi FA, Appelbaum PC. Visalli MA, et al. Antimicrob Agents Chemother. 1997 Apr;41(4):767-70. doi: 10.1128/AAC.41.4.767. Antimicrob Agents Chemother. 1997. PMID: 9087486 Free PMC article. - Another look at trimethoprim-sulfamethoxazole: its role in parenteral therapy.
Sattler FR, Remington JS. Sattler FR, et al. Eur J Clin Microbiol. 1984 Jun;3(3):174-6. doi: 10.1007/BF02014872. Eur J Clin Microbiol. 1984. PMID: 6332015 No abstract available. - Ceftriaxone. A review of its antibacterial activity, pharmacological properties and therapeutic use.
Richards DM, Heel RC, Brogden RN, Speight TM, Avery GS. Richards DM, et al. Drugs. 1984 Jun;27(6):469-527. doi: 10.2165/00003495-198427060-00001. Drugs. 1984. PMID: 6329638 Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical